ABSTRACT
Paving the way for more efficient heart failure treatment and management
In Europe, 6.5 million people battle chronic heart failure (HF), the leading cause of adult hospitalisation with a 5-year mortality rate of 70 %. Current diagnostics for HF are inadequate, leading to ineffective use of diuretics, a cornerstone for symptom relief. The EU-funded BIOTOOL-CHF project aims to revolutionise care with validated biomarkers, an AI-based congestion and prognosis predictor, a decision-making tool for diuretic management and a point-of-care diagnostic. This approach promises to usher in a new era of personalised HF management, optimising existing pharmaceuticals and reducing re-hospitalisations. This innovative approach not only transforms HF management but also sets the stage for personalised strategies in treating HF with reduced ejection fraction.
PARTECIPANTI
- IRCCS Azienda Ospedaliero Universitaria di Bologna (Coordinatore), Italia;
- University Medical Center Groningen, Paesi Bassi;
- Università degli Studi di Brescia, Italia;
- Region Stockholm - Karolinska University Hospital, Svezia;
- Assistance publique hopitaux de Paris, Francia;
- National and Kapodistrian University of Athens, Grecia;
- University Medical Center Ljubljana, Slovenia;
- Germans Trias i Pujol Research Institute, Spagna;
- INCLIVA Foundation, Spagna;
- KU Leuven - Katholieke Universiteit Leuven, Belgio;
- Region Hovedstaden, Danimarca;
- ALMA MATER STUDIORUM - University of Bologna, Italia;
- Onassios Cardiac Surgery Center, Grecia;
- Institut national de la santé et de la recherche médicale, Francia;
- Predict4Health, Francia;
- European Clinical Research Infrastructure Network, Francia;
- Istituto Superiore di Sanità, Italia;
- Tinexta Innovation Hub; Italia;
- University Hospital Schleswig-Holstein, Germania;
- AISC APS - Italian Association of Heart Failure Patients and Cardiovascular Prevention, Germania;
- I.M.A. Industria Macchine Automatiche S.p.A., Italia;
- Erasmus University Rotterdam, Paesi Bassi;
- Fondazione per il tuo cuore ONLUS, Italia;
- University of Applied Sciences and Arts Northwestern Switzerland, Svizzera
Costo totale progetto/contributo UE: € 9 600 663,00
Costo totale/contributo UE per UniBS: € 364.270,00